Minerva Neurosciences reported $36M in Market Capitalization this March of 2022, considering the latest stock price and the number of outstanding shares.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US $ 3.91B 0.15B
Adma Biologics ADMA:US $ 0.36B 0.08B
ALKERMES ALKS:US 4.89B 0.63B
AstraZeneca AZN:LN 167.34B 10.35B
Biocryst Pharmaceuticals BCRX:US $ 1.96B 1.04B
Bristol Myers Squibb BMY:US $ 163.94B 8.45B
Dynavax Technologies DVAX:US $ 1.59B 0.24B
Eli Lilly And LLY:US $ 308.07B 35.35B
Esperion Therapeutics ESPR:US $ 0.4B 0.11B
GlaxoSmithKline GSK:LN 89.77B 6.02B
Halozyme Therapeutics HALO:US $ 5.49B 0.17B
IONIS PHARMACEUT IONS:US $ 5.25B 0.95B
Johnson & Johnson JNJ:US $ 467.1B 1.05B
Marinus Pharmaceuticals MRNS:US $ 0.35B 0.09B
Merk MRK:US $ 230.55B 23.1B
Minerva Neurosciences NERV:US $ 0.04B 0B
Neurocrine Biosciences NBIX:US $ 9.32B 0.36B
Novartis NOVN:VX 194.34B 3.46B
Novavax NVAX:US $ 5.62B 5.2B
Pfizer PFE:US $ 294.18B 1.79B
Roche Holding ROG:VX 300.5B 1.25B
Sanofi SAN:FP 121.89B 4.99B
Takeda 4502:JP 6041.08B 506.36B
Vanda Pharmaceuticals VNDA:US $ 0.62B 0.02B